Acquired amegakaryocytic thrombocytopenia treated with allogeneic: BMT: A case report and review of the literature

Bone Marrow Transplantation

Volumn 24, Issue 12, 1999, Pages 1337-1341

  Lonial, S ^a   Bilodeau, P A ^b   Langston, A A ^a   Lewis, C ^a   Mossavi Sai, S ^a   Holden, J T ^a   Waller, E K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Augusta Oncology Associates   (United States)

Author keywords

Allogeneic BMT; Amegakaryocytic thrombocytopenia

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; DANAZOL; GANCICLOVIR; IMMUNOGLOBULIN; IRON; METHOTREXATE; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VINCRISTINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHIMERA; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MEGAKARYOCYTE; PATHOGENESIS; PRIORITY JOURNAL; SIBLING; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; TREATMENT PLANNING;

EID: 0033371051     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702063     Document Type: Article

References (17)

1. Guerriero A, Worford L, Holland HK et al. Thrombopoietin is synthesized by bone marrow stromal cells. Blood 1997; 90: 3444-3455.
2. Marsh JD, Gibson FM, Prue RL et al. Serum thrombopoietin levels in patients with aplastic anaemia. Br J Haematol 1996; 95: 605-610.
3. Nichol JL. Serum levels of thrombopoietin in health and disease. In: Kuter DJ, Hunt P, Sheridan W, Zucker-Franklin D (eds). Thrombopoiesis and Thrombopoietins. Humana Press: Totowa, NJ, 1997, pp 359-375.
4. Mukai HY, Kojima H, Todokoro K et al. Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much high than those with immune thrombocytopenic purpura. Thromb Haemost 1996; 76: 675-678.
5. Phelan D et al (eds). American Society Histocompalibility and Immunogenetics (ASHI) Laboratory Manual, 3rd edn. ASHI Publications: Lenexa, KS, 2.1-2.8.
6. Hoffman R, Bruno E, Elwell J et al. Acquired amegakaryocytic thrombocytopenic purpura: a syndrome of diverse etiologies. Blood 1982; 60: 1173-1178.
7. Hoffman R. Acquired pure amegakaryocytic thrombocytopenic purpura. Semin Hematol 1991; 28: 303-312.
8. Boggs DR. Amegakaryocytic thrombocytopenia. Am J Hematol 1985; 20: 413-416.
9. Rovira M, Feliu E, Florensa L et al. Acquired amegakaryocytic thrombocytopenic purpura associated with immunoglobulin deficiency. Acta Haematol 1991; 85: 34-36.
10. Trimble MS, Glynn MFX, Brain MC. Amegakaryocytic thrombocytopenia of 4 years duration: successful treatment with antithymocyte globulin. Am J Hematol 1991; 37: 126-127.
11. Kaushansky K, Lok S, Holly LS et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature 1994; 369: 568-571.
12. Henter J-I, Winiarski J, Ljungman P et al. Bone marrow transplantation in two children with congenital amegakaryocytic thrombocytopenia. Bone Marrow Transplant 1996; 18: 799-801.
13. Harjai K, Shah M, Pant A et al. Amegakaryocytic thrombocytopenic purpura. J Postgrad Med 1992; 38: 96-97.
14. El Saghir NS, Geltman RL. Treatment of acquired amegakaryocytic thrombocytopenic purpura with cyclophosphamide. Am J Med 1986; 81: 139-142.
15. King JAC, Elkhalifa MY, Latour LF. Rapid progression of acquired amegakaryocytic thrombocytopenia to aplastic anemia. S Med J 1997; 90: 91-94.
16. Manoharan A, Williams NT, Sparrow R. Acquired amegakaryocytic thrombocytopenia: report of a case and review of literature. Quart J Med 1989; 263: 243-252.
17. Charan VD, Mehrotra R, Pati HP, Choudhry VP. Acquired pure amegakaryocytic thrombocytopenic purpura. J Assoc Phys Ind 1994; 42: 493-494.